Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00284011 · ClinicalTrials.gov registry record · NA
Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT00284011: Completed NA study, sponsored by Mayo Clinic.
NCT00284011 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00284011, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the oral intake of the dietary supplement SAMe increases blood homocysteine levels in healthy human subjects.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT SAMe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00284011
The ClinicalTrials.gov registry entry for NCT00284011 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00284011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00284011 about?
NCT00284011 is a clinical study titled "Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels". The purpose of this study is to determine if the oral intake of the dietary supplement SAMe increases blood homocysteine levels in healthy human subjects.
What is the current status of trial NCT00284011?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2005-06. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00284011?
The interventions under investigation include: Placebo (OTHER), SAMe (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00284011?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.